Hasan Çılgın

Hasan Çılgın

Auto-generated profile, based on publicly available information

Hasan Çılgın

Özel Muayenehane

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2019 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
HÇHasan Çilgin
Hasan Çilgin
Objectives. Some of the social factors were related to hormone replacement therapy. The purpose of this study is to determine hormone replacement therapy (HRT) rates and to illustrate social factors affecting hormone replacement therapy in postmenopausal women. Material and Methods. This study comprised a total of 1052 postmenopausal women, 926 of whom were reported menopausal symptoms and sought for the treatment. 432 of these 926 participants had treated their symptoms by receiving HRT. The data was collected with a data collection form prepared by the researcher by using face-to-face interview technique. In these analyses, chi-square and Backward Logistic regression analyses were used. Results. The multivariate analyses indicated that the decision to seek treatment was influenced by a multitude of factors. These factors included location of hormone replacement therapy (OR: 12.32 [3.21-44.46] in university hospital and OR: 5.42 [2.43–13.26] in private hospital), information received about HRT (OR: 7.25 [2.14,-30.80]), physicians’ counselling and involvement (OR: 5.24 [2.82-9.86]), knowledge of complications associated with HRT (OR: 6.21 [3.28-16.62]), and employment status (OR: 3.42 [1.86-5.58]). The current study identifies these factors affecting the HRT process in postmenopausal women. Conclusion. This study suggests that although the results do not demonstrate an exhaustive list of factors affecting the HRT process, they nonetheless provide evidence that the location participants applied for, physicians’ counselling and involvement, participant employment status, and knowledge surrounding HRT may affect a woman’s intent to receive HRT. Therefore, these results indicate that health professional influence and HRT awareness are important for HRT use. Suggestions for health care include informing women of the advantages and disadvantages of HRT to encourage popularity.

1 December 2024 in Journal of King Saud University – Science
Verified
Journal Article
Open access
SYSerdar YİĞİT
Serdar YİĞİT
IYIsa Yesilyurt
Isa Yesilyurt
SBSoner Bitiktas
Soner Bitiktas
PKPınar Aksu Kilicle
Pınar Aksu Kilicle
LDLale Duysak
Lale Duysak
AKAli Alper Kahraman
Ali Alper Kahraman

2 September 2017 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
HÇHasan Çılgın
Hasan Çılgın
MŞMehmet Şimşek
Mehmet Şimşek
RBRamazan Bal
Ramazan Bal

22 July 2020
Verified
Book Chapter
Open access
PDF file
HÇHasan Çilgin
Hasan Çilgin
The incidence of most cancers increases with age, especially from middle age onward, so today cancer can be considered an age-related disease. One of the keys to healthy and successful aging is reducing the advent of serious disabilities caused by diseases related to aging. One of the cornerstones of anti-aging is hormone replacement therapy to treat age-related diseases caused by sex hormone deficiency in women. However, there are many studies that question the relationship between hormone replacement therapies with cancer recurrence. Hormone replacement therapy (HRT) has the potential to affect both quality of life and survival in menopausal women. Although data in the literature is controversial, many clinicians remain reluctant to write HRT for gynecologic cancer patients due to fear of relapse but HRT does not appear to be associated with an increased risk of relapse in ovarian and endometrial cancer survivors, especially when used for a short period of time.

21 May 2020 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
HÇHasan Çilgin
Hasan Çilgin
Copeptin has been shown to be associated with central nervous system pathologies. The aim of this study was to investigate the relationship between serum CCP levels and central nervous system (CNS) anomalies. In this case-control study, those at 9–14 weeks of gestation serum levels of copeptin, were assessed in pregnant women whose foetuses subsequently developed CNS anomalies (group 1: n = 60) and compared with gestational age-matched pregnant women who exhibited normal pregnancy outcomes (group 2: n = 48). The mean copeptin levels were 1.58 ± 0.40 ng/mL and 1.11 ± 0.36 ng/mL in the CNS anomalies and control groups, respectively (p < .0001). An increased level of copeptin independently predicts development of CNS anomalies, suggesting that copeptin can be used for prediction and discrimination of CNS anomalies in normal pregnancies at 9–14 weeks of gestation.

1 August 2025 in Mediterranean Nursing and Midwifery
Verified
Journal Article
Open access
PDF file
RDRukiye Türk Delibalta
Rukiye Türk Delibalta
TSTuğçe Sönmez
Tuğçe Sönmez
HÇHasan Çılgın
Hasan Çılgın
FTFUSUN TERZIOGLU
FUSUN TERZIOGLU
Objective:This study aimed to compare primary dysmenorrhea, anxiety, depression, quality of life, and sexual life in women who have inserted copper-containing intrauterine devices (TCu380A-IUD) and levonorgestrel-releasing intrauterine devices (LNG-IUD). Method:This comparative, descriptive, cross-sectional study with a pre-test-post-test design was conducted on 160 women, including 80 who received TCu80A-IUDs and 80 who received LNG-IUDs. Data were collected using the visual analog scale, Spielberg state and trait anxiety, Beck depression, short form (SF) 36-quality of life, and Arizona sexual experiences. The data were analyzed by number, percentage, mean, standard deviation, chi-square test, Fisher’s exact test, and t-test for independent/dependent samples. Results:The pain level of the LNG-IUD group was lower at the last follow-up. The levels of anxiety and depression were moderate in both groups. The post-test scores of the SF 36-quality of life scale of the TCu380A-IUD group were statistically significantly higher than those of the LNG-IUD group in physical function, physical and emotional role difficulty (p<0.05). Furthermore, the post-test measures of the LNG-IUD group’s SF 36-quality of life scale were significantly higher than the pre-test in pain, general health, energy/vitality, and mental health (p<0.05). It was noted that at the first follow-up, the ASEX scale scores were similar in both groups. Conclusion:LNG-IUD insertion may be preferred in patients with increased pain and decreased quality of life. Health professionals should provide effective training and counseling services to women using IUDs.